Difference between revisions of "Cao B, et al, N Engl J Med (2020), cited as Ref 81 in DOI:10.1007/s11886-020-01292-3 (Q10590)"
Jump to navigation
Jump to search
(Created claim: Second Author string (P150): Wang Y, #quickstatements; #temporary_batch_1592502960189) |
(Created claim: Third Author string (P151): Wen D, #quickstatements; #temporary_batch_1592503188634) |
||
| Property / Third Author string | |||
| + | Wen D | ||
| Property / Third Author string: Wen D / rank | |||
| + | Normal rank | ||
Revision as of 18:02, 18 June 2020
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Cao B, et al, N Engl J Med (2020), cited as Ref 81 in DOI:10.1007/s11886-020-01292-3
|
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
|
Statements
Q10356 (Deleted Item)
0 references
A trial of Lopinavir-ritonavir in adults hospitalized with severe COVID-19 (English)
0 references
Cao B
0 references
Wang Y
0 references
Wen D
0 references
